These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34786237)

  • 1. Cytomegalovirus Retinitis as a Sole Manifestation of HIV Infection.
    Ferreira Tátá C; Ramires T; Piteira M; Matono R; Guz C
    Cureus; 2021 Oct; 13(10):e18642. PubMed ID: 34786237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.
    Hassan-Moosa R; Chinappa T; Jeena L; Visser L; Naidoo K
    S Afr Med J; 2017 Sep; 107(10):843-846. PubMed ID: 29022526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
    Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
    Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
    Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS
    Retina; 2001; 21(4):339-43. PubMed ID: 11508879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cytomegalovirus retinitis with oral valganciclovir in an acquired immunodeficiency syndrome patient unresponsive to combination antiretroviral therapy.
    Lee CH; Bright DC; Ferrucci S
    Optometry; 2006 Apr; 77(4):167-76. PubMed ID: 16567278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.
    Ude IN; Yeh S; Shantha JG
    Ann Eye Sci; 2022 Mar; 7():. PubMed ID: 35498636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
    Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
    AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual field loss in patients with cytomegalovirus retinitis.
    Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
    Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
    Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated retinopathy in the HAART era.
    Goldberg DE; Smithen LM; Angelilli A; Freeman WR
    Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased visual acuity in patients with cytomegalovirus retinitis and AIDS.
    Raina J; Bainbridge JW; Shah SM
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():8-12. PubMed ID: 10755092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
    Roels P
    Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.